Our results show 44.4% positive immunoreactivity for CTEN, suggesting a strong concordance with the results found in head and neck squamous cell carcinoma in humans, which reported different levels of expression between normal tissues and SCC samples of head and neck tumors [14]. Here, TNS4 is linked to head and neck squamous cell carcinoma.